Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Galpharm Nicotine Replace 2mg medicated chewing gum
0410020B0BMACBA
|
Galpharm nicotine | Nicotine | Central Nervous System | No data available |
|
Galpharm Nicotine Replace 4mg lozenges
0410020B0BMABAZ
|
Galpharm nicotine | Nicotine | Central Nervous System | No data available |
|
Galpharm Nicotine Replace 4mg medicated chewing gum
0410020B0BMADBD
|
Galpharm nicotine | Nicotine | Central Nervous System | No data available |
|
Galpharm Non-Drowsy Allergy Relief 10mg tablets
0304010D0BFABAA
|
Galpharm (Loratadine) | Loratadine | Respiratory System | No data available |
|
Galpharm Non-Drowsy Hayfever and Allergy Relief 10mg tablets
0304010D0BFAAAA
|
Galpharm (Loratadine) | Loratadine | Respiratory System | No data available |
|
Galpharm One a Night Sleep Aid 50mg tablets
0304010N0BTAAAP
|
Galpharm (Diphenhydramine hydrochloride) | Diphenhydramine hydrochloride | Respiratory System | No data available |
|
Galpharm Paracetamol Plus tablets
0407010U0BGAAAA
|
Galpharm (Paracetamol/caffeine) | Paracetamol and caffeine | Central Nervous System | No data available |
|
Galpharm Peppermint Antacid tablets
0101021C0BNAAAF
|
Galpharm (Calcium carbonate) | Calcium carbonate | Gastro-Intestinal System | No data available |
|
Galpharm Period Pain Relief 250mg gastro-resistant tablets
1001010P0BTAAAH
|
Galpharm (Naproxen) | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Galpharm Rapid Ibuprofen lysine 342mg tablets
1001010ADBHAAAB
|
Galpharm (Ibuprofen lysine) | Ibuprofen lysine | Musculoskeletal and Joint Diseases | No data available |
|
Galpharm Single Dose Thrush Treatment 150mg capsules
0502010B0BCAAAB
|
Galpharm (Fluconazole) | Fluconazole | Infections | No data available |
|
Galpharm Six Plus Pain Relief 250mg/5ml oral suspension
0407010H0CPADBG
|
Galpharm (Paracetamol) | Paracetamol | Central Nervous System | No data available |
|
Galpharm Thrush Relief 1% cream
1310020H0BKAAAB
|
Galpharm (Topical) | Clotrimazole | Skin | No data available |
|
Galpharmmedical Antiseptic 0.5% cream
1310050D0BMAAAA
|
Galpharmmedical Antiseptic | Cetrimide | Skin | No data available |
|
Galprofen 100mg/5ml oral suspension
1001010J0CCADBH
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen 200mg tablets
1001010J0CCAAAD
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen Cold and Flu 200mg tablets
1001010J0CCABAD
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen Long Lasting 200mg capsules
1001010J0CCACBA
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen Long Lasting 300mg capsules
1001010J0CCAFAB
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen Migraine Relief 200mg capsules
1001010J0CCAEAA
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galsud 30mg/5ml linctus
0310000N0BTAAAF
|
Galsud | Pseudoephedrine hydrochloride | Respiratory System | No data available |
|
Galsud 60mg tablets
0310000N0BTABAC
|
Galsud | Pseudoephedrine hydrochloride | Respiratory System | No data available |
|
Galsud Decongestant 0.05% nasal spray
1202020G0BHAAAA
|
Galsud (Nasal Spray) | Oxymetazoline hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Galsulfase 5mg/5ml solution for infusion vials
0908010AGAAAAAA
|
Galsulfase | Galsulfase | Nutrition and Blood | No data available |
|
Galsya XL 16mg capsules
0411000F0BCABAF
|
Galsya XL | Galantamine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.